Chattem, Inc.: Clinical Trials

6 trials sponsored by Chattem, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 terminated. 4 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable4Completed 3, Terminated 1
Phase 31Completed 1

Follow Chattem, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Investigational Air-Activated Adhesive-Backed Heat Patch (3-Cell)
Investigational Air-Activated Adhesive-Backed Heat Patch (3-Cell), Temperature Probe - Healthy
Not applicableCompletedChattem, Inc.602014-09-012017-03-17
A Comparative Study to Evaluate Two Air-Activated Adhesive Backed Heat Patches
Thermal Adhesion Patch - Healthy
Not applicableTerminatedChattem, Inc.2002014-03-012020-08-12
A Multicenter Study of Pseudoephedrine for the Temporary Relief of Nasal Congestion in Children With the Common Cold
pseudoephedrine hydrochloride 30 mg tablets, Placebo tablets - Nasal Congestion Associated With the Common Cold
Phase 3CompletedPerrigo Company5652012-11-012016-04-22
Evaluation of Experimental Heat Patch
Thermal Adhesion Patch, Marketed Thermal Adhesion Patch, Placebo Patch - Effects of Heat, Tolerability
Not applicableCompletedChattem, Inc.402012-10-012017-03-17
Evaluation of Experimental and Commercial Air-Activated, Adhesive Backed Heat Patches
Thermal Adhesive Patch, Marketed Thermal Adhesive Patch, Placebo Patch - Effects of Heat, Tolerability
Not applicableCompletedChattem, Inc.1572012-10-012017-03-17
Cumulative Irritation Patch Test
Allergy, Irritation
CompletedChattem, Inc.2242012-09-012013-04-30

Conditions studied

Hypersensitivity (1)  ·  Tissue Adhesions (1)

Interventions

Pseudoephedrine (1)

Countries

United States (6)

Top investigators

Daniel J Hogan, MD (2)  ·  Albert Q. Tejada, MD (1)  ·  Ellen Bonagua, MD (1)  ·  Michael Caswell, PhD (1)